BioPharm International-10-01-2010

Biopharmaceutical Approvals in the US and EU: A Review

Outsourcing Insights

October 01, 2010

Venture capital is still scarce for early biotechs and their providers.

Can vendor-user partnerships overcome the typical wait-and-see attitude toward new technologies?

Biotech approvals were up last year. Is it a sign of a new trend?

How should the industry educate the public about product quality?

A new strategy to streamline vaccine development and oversight.

From the Editor

October 01, 2010

Good leaders look beyond industry woes to focus on patients

Burrill on Biotech

October 01, 2010

Biotech's mid-sized elites position themselves for growth.

Industry and regulators disagree over noncritical parameters.